ROYAL BANK OF CANADA - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 320 filers reported holding EDITAS MEDICINE INC in Q3 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$330,000
+36.4%
42,222
+43.7%
0.00%
Q2 2023$242,000
+50.3%
29,378
+32.4%
0.00%
Q1 2023$161,000
-75.3%
22,190
-69.8%
0.00%
Q4 2022$652,000
-30.3%
73,455
-3.8%
0.00%
Q3 2022$935,000
+6.4%
76,385
+2.9%
0.00%
Q2 2022$879,000
-39.8%
74,231
-3.4%
0.00%
Q1 2022$1,461,000
-10.1%
76,852
+25.6%
0.00%
Q4 2021$1,626,000
-23.5%
61,168
+18.2%
0.00%
-100.0%
Q3 2021$2,126,000
-40.0%
51,734
-17.3%
0.00%0.0%
Q2 2021$3,541,000
+67.2%
62,525
+24.0%
0.00%0.0%
Q1 2021$2,118,000
-74.8%
50,438
-57.9%
0.00%
-50.0%
Q4 2020$8,407,000
+381.5%
119,895
+92.7%
0.00%
+100.0%
Q3 2020$1,746,000
-9.3%
62,229
-4.4%
0.00%0.0%
Q2 2020$1,926,000
+66.6%
65,086
+11.6%
0.00%0.0%
Q1 2020$1,156,000
-31.6%
58,300
+2.1%
0.00%0.0%
Q4 2019$1,691,000
+13.3%
57,115
-13.0%
0.00%0.0%
Q3 2019$1,493,000
-7.7%
65,639
+0.4%
0.00%0.0%
Q2 2019$1,618,000
+7.8%
65,400
+6.5%
0.00%0.0%
Q1 2019$1,501,000
+28.2%
61,395
+19.3%
0.00%0.0%
Q4 2018$1,171,000
-32.0%
51,482
-4.9%
0.00%0.0%
Q3 2018$1,722,000
-11.2%
54,157
+0.1%
0.00%0.0%
Q2 2018$1,939,000
+55.5%
54,116
+43.9%
0.00%0.0%
Q1 2018$1,247,000
+101.5%
37,616
+86.9%
0.00%
Q4 2017$619,000
+85.9%
20,122
+45.2%
0.00%
Q3 2017$333,000
+112.1%
13,858
+48.0%
0.00%
Q2 2017$157,000
-21.9%
9,364
+4.1%
0.00%
Q1 2017$201,000
+91.4%
8,992
+38.4%
0.00%
Q4 2016$105,000
+162.5%
6,496
+118.1%
0.00%
Q3 2016$40,000
+207.7%
2,979
+441.6%
0.00%
Q2 2016$13,000
-92.1%
550
-88.4%
0.00%
Q1 2016$164,0004,7250.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q3 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 1,674,435$51,455,00013.05%
TRV GP III, LLC 906,176$27,847,0009.75%
ARK Investment Management 1,112,845$34,198,0002.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,709,400$52,530,0002.07%
Casdin Capital, LLC 133,333$4,097,0001.00%
Global Thematic Partners, LLC 614,052$18,869,0000.62%
MORGENS WATERFALL VINTIADIS & CO INC 20,000$615,0000.48%
Ghost Tree Capital, LLC 65,000$1,997,0000.47%
ACUTA CAPITAL PARTNERS, LLC 64,000$1,967,0000.37%
VIKING GLOBAL INVESTORS LP 1,709,401$52,530,0000.32%
View complete list of EDITAS MEDICINE INC shareholders